DE3170913D1 - Vaccinal complex containing a specific antigen and vaccine containing it - Google Patents

Vaccinal complex containing a specific antigen and vaccine containing it

Info

Publication number
DE3170913D1
DE3170913D1 DE8181400258T DE3170913T DE3170913D1 DE 3170913 D1 DE3170913 D1 DE 3170913D1 DE 8181400258 T DE8181400258 T DE 8181400258T DE 3170913 T DE3170913 T DE 3170913T DE 3170913 D1 DE3170913 D1 DE 3170913D1
Authority
DE
Germany
Prior art keywords
specific antigen
vaccinal
vaccine
complex
complex containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181400258T
Other languages
English (en)
Inventor
D Hinterland Lucien D Dussourd
Gerard Normier
Anne-Marie Pinel
Jacques Durand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Application granted granted Critical
Publication of DE3170913D1 publication Critical patent/DE3170913D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
DE8181400258T 1980-02-20 1981-02-19 Vaccinal complex containing a specific antigen and vaccine containing it Expired DE3170913D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8003707A FR2475900A1 (fr) 1980-02-20 1980-02-20 Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Publications (1)

Publication Number Publication Date
DE3170913D1 true DE3170913D1 (en) 1985-07-18

Family

ID=9238765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181400258T Expired DE3170913D1 (en) 1980-02-20 1981-02-19 Vaccinal complex containing a specific antigen and vaccine containing it

Country Status (10)

Country Link
US (1) US4460575A (de)
EP (1) EP0035429B1 (de)
JP (1) JPS56131523A (de)
AT (1) ATE13741T1 (de)
AU (1) AU543201B2 (de)
CA (1) CA1181691A (de)
DE (1) DE3170913D1 (de)
ES (1) ES500567A0 (de)
FR (1) FR2475900A1 (de)
ZA (1) ZA811125B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
US5567587A (en) * 1983-01-10 1996-10-22 Gen-Probe Incorporated Method for detecting, the presence and amount of prokaryotic organisms using specific rRNA subsequences as probes
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
JPS62502262A (ja) * 1985-03-27 1987-09-03 ブロンコスタット・プロプライアタリー・リミテツド アジユバントを含有しないワクチン
EP0220308A1 (de) * 1985-04-30 1987-05-06 Scripps Clinic And Research Foundation Die endotoxische aktivität von lipopolysacchariden modulierendes akutphasenprotein, zusammensetzungen und verfahren
US4701323A (en) * 1985-10-23 1987-10-20 Iowa State University Research Foundation, Inc. Vaccines for counteracting inhibition of neutrophil degranulation
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
DE69126183D1 (de) * 1990-08-20 1997-06-26 Den Ichi Mizuno LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
JPH09163896A (ja) * 1995-12-13 1997-06-24 Sumitomo Pharmaceut Co Ltd 胸膜炎病態モデル動物
FR2745186B1 (fr) * 1996-02-26 1998-12-31 Torossian Fernand Narbey Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
GB2325233B (en) * 1997-05-16 2001-07-18 Norsk Hydro As Substrates having bound polysaccharides and bacterial nucleic acids
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
EP2158923B1 (de) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-uricase Konjugate und Verwendung davon
WO2002045742A2 (en) * 2000-09-12 2002-06-13 U.S. Army Medical Research And Materiel Command Lipoteichoic acid immunogenic compositions and methods of making and using thereof
GB2370838A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
GB2370839A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex useful for disease control
WO2003060143A2 (en) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Efficient protein expression system
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
RU2435847C2 (ru) 2005-04-11 2011-12-10 Савиент Фармасьютикалз, Инк. Вариантная форма урат-оксидазы и ее использование
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
ES2532804T3 (es) 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725545A (en) * 1971-02-03 1973-04-03 R Maes Enhancement of antibody production by nucleic acid-polycation complexes
FR2253499B1 (de) * 1973-12-10 1977-11-04 Fabre Sa Pierre
US3952097A (en) * 1974-09-27 1976-04-20 The United States Of America As Represented By The Department Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
FR2305990A1 (fr) * 1975-04-02 1976-10-29 Fabre Sa Pierre Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
FR2360314A2 (fr) * 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales
FR2374911A1 (fr) * 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
FR2388563A1 (fr) * 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
US4285930A (en) * 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy

Also Published As

Publication number Publication date
US4460575A (en) 1984-07-17
ES8203226A1 (es) 1982-04-16
FR2475900B1 (de) 1983-06-10
ES500567A0 (es) 1982-04-16
CA1181691A (en) 1985-01-29
AU6750181A (en) 1981-08-27
EP0035429B1 (de) 1985-06-12
AU543201B2 (en) 1985-04-04
FR2475900A1 (fr) 1981-08-21
JPS56131523A (en) 1981-10-15
ATE13741T1 (de) 1985-06-15
EP0035429A1 (de) 1981-09-09
ZA811125B (en) 1982-03-31

Similar Documents

Publication Publication Date Title
DE3170913D1 (en) Vaccinal complex containing a specific antigen and vaccine containing it
PH20502A (en) Quarternary 6,11-dihydro-dibenzo-(b,e)-thiepine-11-n-alkyl-norscopine ethers
ES8801319A1 (es) Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico.
EP0121249A3 (en) Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
IL65835A0 (en) Protozoal antigen,its preparation and vaccine containing it
ZA817896B (en) Novel d-homosteroids
FR2471785B1 (de)
EP0018579A3 (en) Babesiosis antigen, vaccine and diagnostic reagent comprising it
IL65496A0 (en) Protozoal antigen,its preparation and vaccine containing it
IL59663A0 (en) Vaccines obtained from bacterial mutant strains
ZA905927B (en) Biological preparation and its use
DE3068224D1 (en) Vaccines from taxonomically similar organisms
GR73033B (de)
IL58677A0 (en) Process for the preparation of 1 ,3 -dihydroxy- -steroids and intermediates useful in the process
DE2960853D1 (en) Intra-respiratory vaccine, modified bacteria strain used in it, vaccine dose form and process for preparing it
GB2024223B (en) Process for the preparation of n,n'-disubstituted 2 - naphta - leneethan - imidamides and intermediates used therein
DE69130953T2 (de) Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie
AU6361680A (en) Babesiosis vaccine
IL63957A0 (en) Bis-silylated 1-hydroxycycolopropanecarboxylic acids,their preparation and their use as intermediate products
JPS54140715A (en) Vaccine stabilizer
IT7830203A0 (it) Procedimento per rinforzare prodotti di carbone dolce.
DE2965852D1 (en) Device for driving or extracting intramedullary nails
ZA806606B (en) Specific antigen vaccine for tge in swine
CS194094B1 (en) Vaccine against the aujeszki disease inactivated lyophilizised

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: PIERRE FABRE S.A., BOULOGNE, FR